FITC Anti-Mouse CD3 (17A2)
| Cat No. | Size | Price | Quantity | |
|---|---|---|---|---|
| 35-0032-U025 | 25 µg | $19.00 | ||
| 35-0032-U100 | 100 µg | $52.00 |
Technical Data Sheet
View All Formats
Request Custom/BulkDescription
The 17A2 antibody reacts with the mouse CD3 complex, comprised of CD3 epsilon, CD3 gamma and CD3 delta. These integral membrane protein chains assemble with additional chains of the T cell receptor (TCR), as well as CD3 zeta chain, to form the T cell receptor – CD3 complex. Together with co-receptors CD4 or CD8, the complex serves to recognize antigens bound to MHC molecules on antigen-presenting cells. Such interactions promote T cell receptor signaling (T cell activation) and can result in a number of cellular responses including proliferation, differentiation, production of cytokines or activation-induced cell death. CD3 is differentially expressed during thymocyte-to-T cell development and on all mature T cells.
The 17A2 antibody is a widely used phenotypic marker for mouse T cells. In addition, as the CD3e chain within the TCR complex contains intracellular signaling domains, binding of 17A2 antibody to CD3 can induce cell activation (use format suitable for functional assays). A recent publication of the crystal structure of a murine CD3e-mitogenic antibody complex provides further insight into the action of commonly used agonist antibodies (Fernandes, R.A. et al. 2012. Journal of Biological Chemistry. 287: 13324-13335).
Recent Citations:
Alam MM, Yang D, Li XQ, Liu J, Back TC, Trivett A, Karim B, Barbut D, Zasloff M, Oppenheim JJ. Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function. Cell Rep. 2022 Jan 11;38(2):110090. doi: 10.1016/j.celrep.2021.110090. PMID: 35021075.
Rappe JCF, Finsterbusch K, Crotta S, Mack M, Priestnall SL, Wack A. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza. J Exp Med. 2021 Nov 1;218(11):e20201631. doi: 10.1084/jem.20201631. Epub 2021 Sep 2. PMID: 34473195.
The 17A2 antibody reacts with the mouse CD3 complex, comprised of CD3 epsilon, CD3 gamma and CD3 delta. These integral membrane protein chains assemble with additional chains of the T cell receptor (TCR), as well as CD3 zeta chain, to form the T cell receptor – CD3 complex. Together with co-receptors CD4 or CD8, the complex serves to recognize antigens bound to MHC molecules on antigen-presenting cells. Such interactions promote T cell receptor signaling (T cell activation) and can result in a number of cellular responses including proliferation, differentiation, production of cytokines or activation-induced cell death. CD3 is differentially expressed during thymocyte-to-T cell development and on all mature T cells.
The 17A2 antibody is a widely used phenotypic marker for mouse T cells. In addition, as the CD3e chain within the TCR complex contains intracellular signaling domains, binding of 17A2 antibody to CD3 can induce cell activation (use format suitable for functional assays). A recent publication of the crystal structure of a murine CD3e-mitogenic antibody complex provides further insight into the action of commonly used agonist antibodies (Fernandes, R.A. et al. 2012. Journal of Biological Chemistry. 287: 13324-13335).
Recent Citations:
Alam MM, Yang D, Li XQ, Liu J, Back TC, Trivett A, Karim B, Barbut D, Zasloff M, Oppenheim JJ. Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function. Cell Rep. 2022 Jan 11;38(2):110090. doi: 10.1016/j.celrep.2021.110090. PMID: 35021075.
Rappe JCF, Finsterbusch K, Crotta S, Mack M, Priestnall SL, Wack A. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza. J Exp Med. 2021 Nov 1;218(11):e20201631. doi: 10.1084/jem.20201631. Epub 2021 Sep 2. PMID: 34473195.
Product Details
| Name | FITC Anti-Mouse CD3 (17A2) |
|---|---|
| Cat. No. | 35-0032 |
| Alternative Names | |
| Gene ID | |
| Clone | 17A2 |
| Isotype | Rat IgG2b, κ |
| Reactivity | Mouse |
| Cross Reactivity | |
| Format | FITC |
| Application | Flow Cytometry |
| Citations* |
Clark PA, Sriramaneni RN, Jin WJ, et al. In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases. Journal for ImmunoTherapy of Cancer 2020;8:e000809. doi: 10.1136/jitc-2020-000809. Joetham A, Ohnishi H, Okamoto M, Takeda K, Schedel M, Domenico J, Dakhama A, and Gelfand EW. 2012. J. Biol. Chem. 287:17100-17108. (in vitro activation) Kasahara S and Clark, EA. 2012. J. Leukoc. Biol. 91:437-448. (in vitro activation) Xiao J, Julianty A, Wen J, Smith SV, Park PW, Ford ML, Haller CA, and Chaikof EL. 2012. Arterioscler. Thromb. Vasc. Biol. 32:386-396. (in vivo T cell depletion) Miescher GC, Schreyer M, and MacDonald HR. 1989. Immunol. Lett. 23: 113-118. (Origination of clone 17A2, Functional Assay, Immunohistochemistry, Immunoprecipitation) |
FC = Flow Cytometry; FA = Functional Assays; ELISA = Enzyme-Linked Immunosorbent Assay; ICC = Immunocytochemistry; IF = Immunofluorescence Microscopy; IHC = Immunohistochemistry; IHC-F = Immunohistochemistry, Frozen Tissue; IHC-P = Immunohistochemistry, Paraffin-Embedded Tissue; IP = Immunoprecipitation; WB = Western Blot; EM = Electron Microscopy
*Tonbo Biosciences tests all antibodies by flow cytometry. Citations are provided as a resource for additional applications that have not been validated by Tonbo Biosciences. Please choose the appropriate format for each application and consult the Materials and Methods section for additional details about the use of any product in these publications.